These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26327689)

  • 1. 5-HTTLPR and use of antidepressants after colorectal cancer including a meta-analysis of 5-HTTLPR and depression after cancer.
    Suppli NP; Bukh JD; Moffitt TE; Caspi A; Johansen C; Albieri V; Tjønneland A; Kessing LV; Dalton SO
    Transl Psychiatry; 2015 Sep; 5(9):e631. PubMed ID: 26327689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M
    Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder.
    Ren F; Ma Y; Zhu X; Guo R; Wang J; He L
    J Affect Disord; 2020 Aug; 273():254-264. PubMed ID: 32421611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression.
    Culverhouse RC; Bowes L; Breslau N; Nurnberger JI; Burmeister M; Fergusson DM; Munafò M; Saccone NL; Bierut LJ;
    BMC Psychiatry; 2013 Nov; 13():304. PubMed ID: 24219410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics; 2006 Mar; 7(2):159-66. PubMed ID: 16515395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.
    Karg K; Burmeister M; Shedden K; Sen S
    Arch Gen Psychiatry; 2011 May; 68(5):444-54. PubMed ID: 21199959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HTTLPR modulates antidepressant efficacy in depressed women.
    Gressier F; Bouaziz E; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Psychiatr Genet; 2009 Aug; 19(4):195-200. PubMed ID: 19451862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis.
    Gao L; Gao H
    Mol Biol Rep; 2014 Sep; 41(9):6071-82. PubMed ID: 24972569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.
    Risch N; Herrell R; Lehner T; Liang KY; Eaves L; Hoh J; Griem A; Kovacs M; Ott J; Merikangas KR
    JAMA; 2009 Jun; 301(23):2462-71. PubMed ID: 19531786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HTTLPR genotype, asthma, diabetes and late-life depression in an older French population.
    Omari-Asor L; Stewart R; Artero S; Ritchie K
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1017-22. PubMed ID: 25640317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social support and the serotonin transporter genotype (5-HTTLPR) moderate levels of resilience, sense of coherence, and depression.
    Reinelt E; Barnow S; Stopsack M; Aldinger M; Schmidt CO; John U; Grabe HJ
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):383-91. PubMed ID: 25989139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant response and the serotonin transporter gene-linked polymorphic region.
    Taylor MJ; Sen S; Bhagwagar Z
    Biol Psychiatry; 2010 Sep; 68(6):536-43. PubMed ID: 20615496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
    Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
    Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter gene (5-HTTLPR) polymorphism and efficacy of selective serotonin reuptake inhibitors--do we have sufficient evidence for clinical practice.
    Karlović D; Karlović D
    Acta Clin Croat; 2013 Sep; 52(3):353-62. PubMed ID: 24558768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.
    Mak KK; Kong WY; Mak A; Sharma VK; Ho RC
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):322-8. PubMed ID: 23236014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipated outcomes from introduction of 5-HTTLPR genotyping for depressed patients: an expert Delphi analysis.
    Oestergaard S; Møldrup C
    Public Health Genomics; 2010; 13(7-8):406-14. PubMed ID: 20606382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression?
    Wankerl M; Wüst S; Otte C
    Curr Opin Psychiatry; 2010 Nov; 23(6):582-7. PubMed ID: 20881788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No interaction between serotonin transporter gene (5-HTTLPR) polymorphism and adversity on depression among Japanese children and adolescents.
    Tomoda A; Nishitani S; Matsuura N; Fujisawa TX; Kawatani J; Toyohisa D; Ono M; Shinohara K
    BMC Psychiatry; 2013 May; 13():134. PubMed ID: 23663729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis.
    Suppli NP; Bukh JD; Moffitt TE; Caspi A; Johansen C; Tjønneland A; Kessing LV; Dalton SO
    Depress Anxiety; 2017 Sep; 34(9):845-855. PubMed ID: 28590587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.